125 related articles for article (PubMed ID: 23379599)
1. Muscle atrophy beyond the clinical effect after a single dose of OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic resonance imaging.
Koerte IK; Schroeder AS; Fietzek UM; Borggraefe I; Kerscher M; Berweck S; Reiser M; Ertl-Wagner B; Heinen F
Dermatol Surg; 2013 May; 39(5):761-5. PubMed ID: 23379599
[TBL] [Abstract][Full Text] [Related]
2. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
Prager W; Rappl T
J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
[TBL] [Abstract][Full Text] [Related]
3. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
Alimohammadi M; Andersson M; Punga AR
Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
[TBL] [Abstract][Full Text] [Related]
4. Atrophy of corrugator supercilii muscle in a patient induced by the onabotulinum toxin injection.
Zhao CH; Stillman M
Headache; 2012 Feb; 52(2):309-11. PubMed ID: 22085341
[TBL] [Abstract][Full Text] [Related]
5. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: muscle atrophy after motor end plate-targeted injections.
Van Campenhout A; Verhaegen A; Pans S; Molenaers G
Res Dev Disabil; 2013 Mar; 34(3):1052-8. PubMed ID: 23295965
[TBL] [Abstract][Full Text] [Related]
7. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
Lorenc ZP; Smith S; Nestor M; Nelson D; Moradi A
Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
[TBL] [Abstract][Full Text] [Related]
8. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
10. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
Pribitkin EA; Greco TM; Goode RL; Keane WM
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):321-6. PubMed ID: 9076240
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of the onset and longevity of the action of incobotulinumtoxinA by skin displacement analysis in the treatment of glabellar frown lines.
Proebstle TM; Chung G; Weissberg R; Pavicic T
J Drugs Dermatol; 2014 Sep; 13(9):1067-72. PubMed ID: 25226007
[TBL] [Abstract][Full Text] [Related]
12. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
Fabi SG; Sundaram H; Guiha I; Goldman MP
J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
[TBL] [Abstract][Full Text] [Related]
13. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
Alster TS; Lupton JR
Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A reconstituted in lidocaine with epinephrine for facial rejuvenation: results of a participant satisfaction survey.
Kim A; Jung J; Pak A
Cutis; 2013 Jul; Suppl():13-8. PubMed ID: 24308152
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin A on facial wrinkle lines in Koreans.
Lew H; Yun YS; Lee SY; Kim SJ
Ophthalmologica; 2002; 216(1):50-4. PubMed ID: 11901289
[TBL] [Abstract][Full Text] [Related]
17. DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).
Bertucci V; Solish N; Kaufman-Janette J; Yoelin S; Shamban A; Schlessinger J; Snyder D; Gallagher C; Liu Y; Shears G; Rubio RG
J Am Acad Dermatol; 2020 Apr; 82(4):838-845. PubMed ID: 31791824
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study.
Kane MAC; Brandt F; Rohrich RJ; Narins RS; Monheit GD; Huber MB;
Plast Reconstr Surg; 2009 Nov; 124(5):1619-1629. PubMed ID: 19584772
[TBL] [Abstract][Full Text] [Related]
19. [Controversy: botulinum toxin, does it prevent cutaneous aging?].
Cohen-Letessier A
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492
[TBL] [Abstract][Full Text] [Related]
20. OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines.
Cohen JL; Dayan SH; Cox SE; Yalamanchili R; Tardie G
Dermatol Surg; 2012 Sep; 38(9):1497-505. PubMed ID: 22621180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
